| BBB | Blood–brain barrier |
| CHMP2A | Charged multivesicular body protein 2A |
| DMT1 | Divalent metal transporter 1 |
| DEGs | Differentially expressed genes |
| DABG | Detection above background |
| DMPS | 3-dimercapto-propanesulphonate |
| FADD | Fas-associated death domain protein |
| FDR | False discovery rate |
| GCN2/EIF2K4 | Eukaryotic translation initiation factor 2 alpha kinase 4 |
| HDAC10 | Histone deacetylase 10 |
| IPA | Ingenuity Pathway Analysis |
| IRPs | Iron regulatory proteins |
| KNL1 | Kinetochore scaffold 1 |
| LRP6 | LDL receptor-related protein 6 |
| MED21 | Mediator complex subunit 21 |
| NAC | N-acetyl-cysteine |
| NR2C2 | Nuclear receptor subfamily 2 group C member 2 |
| NSD2 | Nuclear receptor binding SET domain protein 2 |
| PSMD13 | Proteasome 26S subunit, non-ATPase 13 |
| RAR | Retinoic acid receptor |
| SD | Standard deviation |
| UBE2A | Ubiquitin-conjugating enzyme E2 A |
| UPLC-HRMS/MS | Ultra-performance liquid chromatography–high-resolution tandem mass spectrometry |